Molecular Target Synopsis
Overview
Domains and Structures
Drugs and Clinical Candidates
Druggability
Chemistry
Ligand Efficiency Plot
Pathways
Family Cladogram
Interaction Network
Gene Expression
Gene Copy Number Variation
RNAi
Mutations
Germline Genetics

hipA (P23874) - Overview - Molecular Target Synopsis

Protein


hipA, Serine/threonine-protein kinase toxin HipA
Enzyme Classification 2.7.11.1
UniProt P23874

Also Known as HIPA_ECOLI, hipA

Toxic component of a type II toxin-antitoxin (TA) system, first identified by mutations that increase production of persister cells, a fraction of cells that are phenotypic variants not killed by antibiotics, which lead to multidrug tolerance (PubMed:6348026, PubMed:8021189, PubMed:16707675, PubMed:26222023). Persistence may be ultimately due to global remodeling of the persister cell's ribosomes (PubMed:25425348). Phosphorylates Glu-tRNA-ligase (AC P04805, gltX, on 'Ser-239') in vivo (PubMed:24095282, PubMed:24343429). Phosphorylation of GltX prevents it from being charged, leading to an increase in uncharged tRNA(Glu). This induces amino acid starvation and the stringent response via RelA/SpoT and increased (p)ppGpp levels, which inhibits replication, transcription, translation and cell wall synthesis, reducing growth and leading to persistence and multidrug resistance (PubMed:24095282, PubMed:24343429, PubMed:25848049). Once the level of HipA exceeds a threshold cells become dormant, and the length of dormancy is determined by how much HipA levels exceed the threshold (PubMed:20616060). The hipA7 mutation (a double G22S D291A mutation) leads to increased generation of persister cells (cells that survive antibiotic treatment) probably by entering into a dormant state, as well as cold-sensitivity (PubMed:14622409, PubMed:16707675). Wild-type cells produce persisters at a frequency of 10(-6) to 10(-5) whereas hipA7 cells produce about 100-fold more persisters (PubMed:14622409, PubMed:16707675, PubMed:25425348). hipA7 decreases the affinity for antitoxin HipB, leading to increased HipA levels and persistence (PubMed:20616060); depending on the protein level, can be toxic enough to reduce cell growth or even kill cells. Generation of persister cells requires (p)ppGpp as cells lacking relA or relA/spoT generate fewer or no persister cells respectively compared to hipA7 (PubMed:14622409, PubMed:25848049). Generation of persister cells by HipA also requires mRNA interferase toxins (such as MazF, RelE or YafO) and Lon protease; a strain deleted for 10 type II TAs does not produce persisters when HipA (or HipA7) is expressed, nor does a lon deletion strain or bacteria with alterations of polyphosphate levels, although levels of (p)ppGpp increase (PubMed:25848049). The toxic effect of HipA is neutralized by its cognate antitoxin HipB (PubMed:20616060). Also neutralized by overexpression of gltX (PubMed:24343429, PubMed:28430938). With HipB acts as a corepressor for transcription of the hipBA promoter (PubMed:8021189); binding of HipA-HipB to DNA induces a 70 degree bend (PubMed:19150849, PubMed:26222023). This brings together and dimerizes 2 HipA molecules, which distorts the promoter region, preventing sigma-factor binding; additionally HipA and HipB would physically prevent RNA core polymerase from contacting the -35 promoter box (PubMed:26222023). May play a role in biofilm formation (PubMed:23329678). Forms a HipA(2)HipB(2) heterotetramer which can interact with a single operator on DNA (PubMed:19150849). When 2 operators are present each HipB dimer contacts 1 HipA molecule, which are brought together by the DNA bend and dimerize, blocking the HipA active site and inactivating its toxic activity (PubMed:26222023). Mutations present in allele hipA7 (G22S and D291A) decrease the affinity of HipA for HipB (PubMed:20616060).

5K98
STRUCTURE OF HIPA-HIPB-O2-O3 COMPLEX
RCSB/PDB
Inspect Structure
See all 3D Structures for hipA

Isoforms / Transcripts (Protein Coding)


Protein Length Ensembl Gene Ensembl Transcript Ensembl Protein Uniprot Isoform
440P23874-1

Sub-cellular localization


GO terms: hipA is active in the following subcellular-locations: cytosol, protein-DNA complex.



UniProt
GO terms

Gene Copy Number Variation


In COSMIC - Cell Lines Project hipA has gain in 0 cell-lines, loss in 0 cell-lines and no signal in 0 cell-lines. (see details)

3D Structures


For hipA there are:
13 structures (18 chains) solved
5 are solved in complex with at least one small molecule ligand



(see details)
Molecular Target 3D Synopsis